Stocks to sell

Novavax (NASDAQ:NVAX) stock hasn’t had a great 2022, down 86% since the beginning of the year. The company focuses on products to treat infectious diseases but is definitely best known for its Covid-19 vaccine NVX-CoV2373, also known as Nuvaxovid. There are plenty of other competing vaccines in this category, and Novavax’s shots haven’t been strong sellers
0 Comments
There’s been some drama surrounding Cassava Sciences (NASDAQ:SAVA) recently. First, there was a report stating that the Securities and Exchange Commission, or SEC, cleared Cassava Sciences of charges of manipulating research results. Not long afterward, however, Cassava disputed the legitimacy of that report. These twists and turns in the ongoing story make it difficult to recommend
0 Comments
Sometimes, you just have to let go of a thesis when it’s proven wrong. Stubborn investors might try to average down on microprocessor manufacturer Intel (NASDAQ:INTC) stock. That’s not a wise move to make, though, as even the company’s management had to acknowledge challenging market conditions. If you’re only in it for the dividend payouts, don’t
0 Comments
Over the past two months, sentiment for FuboTV (NYSE:FUBO) stock has gone from “game over” to “game on.” Hitting a new low of $2.32 per share in late July, FUBO stock briefly spiked to above $6 per share in August as the result of an extremely positive response its first investor day presentation. Although this
0 Comments
When a company’s CEO is frustrated, that’s probably not a good sign for investors. Today’s case in point is Palantir Technologies (NYSE:PLTR) stock, which seems to be having difficulty with some government contracts as their timing can be problematic. Furthermore, Palantir’s disappointing forward guidance could easily be a deal-breaker for prospective PLTR stock investors. Don’t get
0 Comments
It is probably the right time for you to think about some marijuana stocks to sell. Marijuana stocks have been a massive downer this year. The selloff in risky stocks has been particularly hard on the marijuana sector. One of the leading funds tracking the sector is the AdvisorShares Pure Cannabis ETF, which has lost
0 Comments
SoFi Technologies (NASDAQ:SOFI) stock has been a disappointment for investors. From the outset, the neo-banking firm was supposed to disrupt the American financial sector. Yet, that vision hasn’t become a reality in the 2020s. Long-term SOFI stockholders are still struggling to break even. Tight central bank monetary policy certainly won’t make things easier for SoFi Technologies. Besides,
0 Comments
Rising interest rates are cooling off the U.S. housing market. The average interest rate on a 30-year mortgage, the most popular U.S. home loan, has risen to 6% for the first time since the 2008 financial crisis. Consequently, mortgage loan applications in the U.S. are down 64% from this time last year. Higher interest rates
0 Comments